SPS
Susquehanna Portfolio Strategies Portfolio holdings
AUM
$6.48B
1-Year Est. Return
33.86%
This Fund
S&P 500
1 Year Est. Return
+33.86%
AUM
$6.48B
AUM Growth
+$173M
(+2.7%)
Holding
1,156
Top Buys
| 1 | +$63.6M | |
| 2 | +$59.1M | |
| 3 | +$48.4M | |
| 4 |
McDonald's
MCD
|
+$48M |
| 5 |
Walt Disney
DIS
|
+$43M |
Top Sells
| 1 | +$39.7M | |
| 2 | +$35.8M | |
| 3 | +$33.4M | |
| 4 |
Cheniere Energy
LNG
|
+$31.2M |
| 5 |
MetLife
MET
|
+$29M |
Sector Composition
| 1 | Healthcare | 18.09% |
| 2 | Consumer Discretionary | 15.77% |
| 3 | Technology | 12.68% |
| 4 | Financials | 11.64% |
| 5 | Energy | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
O-I Glass
OI
$1.91B
| $202K | ﹤0.01% |
13,656
-10,144
|
|
||
952
Aura Biosciences
AURA
$396M
| $197K | ﹤0.01% |
36,090
-20,708
|
|
||
953
GeoPark
GPRK
$427M
| $190K | ﹤0.01% |
+25,683
|
|
||
954
Stoneridge
SRI
$211M
| $189K | ﹤0.01% |
32,601
-24,587
|
|
||
|
AGEN
955
Agenus
AGEN
$115M
| $187K | ﹤0.01% |
59,413
-108,808
|
|
||
956
Northwest Bancshares
NWBI
$1.84B
| $185K | ﹤0.01% |
15,428
|
|
||
957
Allot
ALLT
$335M
| $184K | ﹤0.01% |
18,753
-7,500
|
|
||
958
Douglas Elliman
DOUG
$203M
| $180K | ﹤0.01% |
75,890
-14,850
|
|
||
959
eXp World Holdings
EXPI
$1.13B
| $178K | ﹤0.01% |
+19,627
|
|
||
960
Mercer International
MERC
$115M
| $176K | ﹤0.01% |
88,938
-25,259
|
|
||
961
X4 Pharmaceuticals
XFOR
$291M
| $173K | ﹤0.01% |
+43,259
|
|
||
962
Gaotu Techedu
GOTU
$528M
| $169K | ﹤0.01% |
+72,909
|
|
||
963
Hayward Holdings
HAYW
$3.38B
| $161K | ﹤0.01% |
10,429
-40,637
|
|
||
964
CryoPort
CYRX
$425M
| $157K | ﹤0.01% |
16,366
-5,585
|
|
||
965
Sally Beauty Holdings
SBH
$1.51B
| $143K | ﹤0.01% |
+10,026
|
|
||
966
Conduent
CNDT
$220M
| $140K | ﹤0.01% |
73,016
|
|
||
967
Bumble
BMBL
$340M
| $137K | ﹤0.01% |
38,271
-62,790
|
|
||
968
Vor Biopharma
VOR
$621M
| $134K | ﹤0.01% |
+10,207
|
|
||
969
Pulmonx
LUNG
$63.1M
| $133K | ﹤0.01% |
+60,259
|
|
||
|
RERE
970
ATRenew
RERE
$1.19B
| $131K | ﹤0.01% |
24,796
|
|
||
971
Organogenesis Holdings
ORGO
$364M
| $131K | ﹤0.01% |
25,294
-14,024
|
|
||
|
OTLY
972
Oatly Group
OTLY
$356M
| $131K | ﹤0.01% |
12,240
-9,786
|
|
||
973
Neumora Therapeutics
NMRA
$520M
| $129K | ﹤0.01% |
72,106
+30,866
|
|
||
974
Precigen
PGEN
$1.26B
| $127K | ﹤0.01% |
30,482
+11,457
|
|
||
975
Aclaris Therapeutics
ACRS
$329M
| $120K | ﹤0.01% |
+39,701
|
|